$AGYS

Agilysys CEO Ramesh Srinivasan sells $21.3m in company stock

Agilysys (NASDAQ:AGYS) CEO Ramesh Srinivasan sold 197,410 shares of common stock from Aug. 5 to Aug. 7, for about $21.3 million at weighted average prices of $106.60 to $109.63. After the sales, he directly holds 610,044 shares. The article also cites Agilysys fiscal Q1 2027 results and raised guidance, with analysts updating price targets.

Original reporting
Published Aug 8, 2026, 8:17 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 12:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$AGYS
Neutral
medium confidence
Mentioned
$AGYS
Relevance
4/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$AGYSNeutralLow
01

Why it matters

Traders may reassess near-term sentiment around AGYS due to the disclosed insider selling, but the article does not introduce new negative company fundamentals beyond the transaction itself.

02

Market read

Primary actionable item is the disclosed insider sale size and pricing; the rest is a recap of previously reported results and analyst target changes.

03

What to watch

The text does not state whether sales were pre-planned under a Rule 10b5-1 plan, nor does it quantify CEO compensation, option exercises, or net insider buying/selling trends beyond this window.

Relevance 4/10Novelty 4/10Timing: today’s premarket read-through on insider selling and recent guidance narrative

Background

The piece centers on CEO Ramesh Srinivasan’s multi-day stock sales, alongside a recap of Agilysys’s strong fiscal first-quarter 2027 results and guidance updates.

Company-level read

Ticker impact

$AGYSNeutralMedium confidence
Context

Agilysys CEO Ramesh Srinivasan sold 197,410 shares for about $21.3m at weighted-average prices from $106.60 to $109.63.

Expected impact

Near-term sentiment risk, but likely limited fundamental impact unless paired with additional negative disclosures.

Evidence & confidence

This is a Form 4-style insider transaction writeup with specific share counts and prices, but it does not provide a stated reason for selling or new operational deterioration.

Market effects

Limited sector read-through; insider selling is company-specific and not a broad software/IT services signal by itself.

No clear regional spillover beyond US small/mid-cap sentiment.

Minimal global relevance; the disclosure is tied to a US-listed issuer.

Counterpoint

The CEO sale may be routine diversification or tax-related, so it may not reflect bearish fundamentals given the article also cites strong quarterly results and raised guidance.

Key entities

  • Agilysys Inc

    NASDAQ-listed company whose CEO sold 197,410 shares totaling about $21.3m over Aug 5 to Aug 7, 2026.

  • Ramesh Srinivasan

    President and CEO of Agilysys who sold shares at weighted-average prices between $106.60 and $109.63.

Related articles

$AGYSHighAI 8/10

Why Agilysys (AGYS) Stock Is Up Today

Agilysys (NASDAQ: AGYS) shares rose 11.6% after the company reported Q2 results above expectations and raised full-year revenue guidance. Revenue was $87.68M vs $86.2M expected, with adjusted EPS $0.49 vs $0.40. Full-year revenue guidance midpoint was lifted to $370.5M.

$AGYSMed

Agilysys Inc (AGYS) Q1 2027 Earnings Call Highlights: Record Revenue and Raised Guidance

Agilysys (AGYS) reported Q1 2027 earnings call highlights, citing record revenue and raised guidance. The CFO said the increase was driven by stronger-than-expected subscription sales and backlog conversion, while product and professional services remain within prior guidance. CEO comments covered RFP win rates, Marriott PMS rollout lessons, price-sensitive markets, and AI’s role in hospitality software.

$AGYSMedAI 8/10

Agilysys: Fiscal Q1 Earnings Snapshot

Agilysys Inc. (AGYS) reported fiscal Q1 profit of 32 cents per share, or 49 cents adjusted, versus Zacks’ four-analyst estimate of 40 cents. Revenue was $87.7 million versus $85.9 million expected. Full-year revenue guidance is $368 million to $373 million. Shares were down 13% YTD, ending Monday at $103.24.

$AGYSMed

Agilysys (NASDAQ:AGYS) Surprises With Q2 CY2026 Sales

Agilysys (NASDAQ:AGYS) reported Q2 CY2026 revenue of $87.68 million, up 14.3% year on year and 1.7% above Wall Street estimates. Full-year revenue guidance midpoint is $370.5 million, 0.7% above consensus. Non-GAAP EPS was $0.49, 21.7% above consensus, with subscription growth of 26% and professional services revenue of $19.6 million.